Drug Profile
Research programme: cancer vaccines - Pan-Provincial Vaccine Enterprise
Latest Information Update: 30 Aug 2011
Price :
$50
*
At a glance
- Originator Pan-Provincial Vaccine Enterprise
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 29 Aug 2011 Early research in Cancer in Canada (unspecified route)